Acute heart failure due to fulminant and giant cell myocarditis

Herz

Volumn 31, Issue 8, 2006, Pages 767-770

  Cooper Jr , Leslie T ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acute heart failure syndrome; Dilated cardiomyopathy; Myocarditis

Indexed keywords

CYCLOSPORIN; STEROID;

ACUTE HEART FAILURE; CARDIOMYOPATHY; DEATH; DISEASE SEVERITY; GIANT CELL; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG ARTERY PRESSURE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL TIME; SYNCOPE;

ACUTE DISEASE; CARDIAC OUTPUT, LOW; GRANULOMA, GIANT CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYOCARDITIS; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 33845579644     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2917-4     Document Type: Review

References (26)

1. Adams K, Lindenfeld J, Arnold J, et al. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006;12:10-38.
2. Cooper LT Jr, Onuma OK. Myocarditis. In: Murphy JG, Lloyd MA, eds. Mayo Clinic cardiology: concise textbook, 3rd edn. Rochester: Mayo Clinic Scientific Press, and New York: Informa Healthcare USA, 2007:1125-38.
3. Felker G, Thompson R, Hare J, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342:1077-84.
4. Lieberman EB, Hutchins GM, Herskowitz A, et al. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991;18:1617-26.
5. McCarthy RE, 3rd, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-5.
6. Felker GM, Boehmer JP, Hruban RH, et al. Echocardiographic findings in fulminant and acute. J Am Coll Cardiol 2000;36:227-32.
7. Amabile NF, Bouvenot A, Chetaille J, et al. Outcome of acute fulminant myocarditis in children. Heart 2006;92:1269-73.
8. Cooper, LT. Gersh, BJ. Viral infection, inflammation, and the risk of idiopathic dilated cardiomyopathy: can the fire be extinguished? Am J Cardiol 2002;90:751-4.
9. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006;113:593-5.
10. Chow LH, Radio SJ, Sears TD, et al. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989;14:915-20.
11. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64:1235-45.
12. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
13. Laissy JP, Hyafil F, Feldman LJ, et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. Radiology 2005;237:75-82.
14. Dec GW. Introduction to clinical myocarditis. In: Cooper LT, ed. Myocarditis: from bench to bedside. Totowa: Humana Press, 2003:257-81.
15. Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997;95:163-8.
16. Fuse K, Kodama M, Okura Y, et al. Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis. Eur J Heart Fail 2005;7:109-12.
17. Fuse K, Kodama M, Okura Y, et al. Predictors of disease course in patients with acute myocarditis. Circulation 2000;102:2829-35.
18. Mendes LA, Dec GW, Picard MH, et al. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 1994;128:301-7.
19. Naqvi TZ, Goel RK, Forrester JS, et al. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999;34:1537-44.
20. Kilgallen C, Jackson E, Bankoff M, et al. A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy. Clin Cardiol 1998;21:48-51.
21. Daniels P, Tazelaar H, Edwards W, et al. Hypersensitivity myocarditis presenting histologically with fulminant giant cell myocarditis. Cardiovasc Pathol 2000;9:287-91.
22. Okura Y, Dec G, Hare J, et al. A multicenter registry comparison of cardiac sarcoidosis and giant cell myocarditis. Circulation 2000;102:Suppl II:3897.
23. Herzog C, Snover D, Staley N. Acute necrotising eosinophilic myocarditis. Br Heart J 1984;52:343-8.
24. DeMello DE, Liapis H, Jureidini S, et al. Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med 1990;323:1542-5.
25. Wu L, Cooper LT, Kephart G, et al.The eosinophil in cardiac disease. In: Cooper L, ed. Myocarditis: from bench to bedside.Totowa: Humana Press, 2002:437-53.
26. Cooper LT, Zehr KJ. Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis. Nat Clin Pract Cardiovasc Med 2005;2:544-8.